Prevalence of active hepatitis c virus infection in district mansehra pakistan

Virology Journal

Volumn 7, Issue , 2010, Pages

  Ali, Amjad ^a   Ahmad, Habib ^a   Ali, Ijaz ^b   Khan, Sheema ^c   Zaidi, Gulshan ^d   Idrees, Muhammad ^d  

^a HAZARA UNIVERSITY   (Pakistan)

^b THE UNIVERSITY OF AGRICULTURE   (Pakistan)

^c KHYBER TEACHING HOSPITAL   (Pakistan)

^d UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GROUPS BY AGE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAKISTAN; POLYMERASE CHAIN REACTION; PREVALENCE; SCHOOL CHILD; SCREENING TEST; SEX DIFFERENCE; VIRUS DETECTION; AGE; AGED; ASYMPTOMATIC DISEASE; BLOOD; HETEROZYGOTE; INCIDENCE; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

HEPATITIS C VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; BLOOD; CARRIER STATE; CHILD; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PAKISTAN; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; YOUNG ADULT;

EID: 78549294558     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-334     Document Type: Article

References (34)

1. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. SA Villano D Vlahov KE Nelson S Cohn DL Thomas, Hepatology 1999 29 3 908 914 10.1002/hep.510290311 10051497
2. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. MJ Alter HS Margolis K Krawczynski FN Judson A Mares WJ Alexander PY Hu, N Engl J Med 1992 327 1899 1905 10.1056/NEJM199212313272702 1280771
3. New Hepatitis C Virus (HCV) Genotyping System that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a and 6a. T Ohno M Mizokami RR Wu MG Saleh KI Ohba E Orito M Mukaide R Williams JYN Lau, J Clin Microbiol 1997 35 201 207 8968908
4. Antibodies Against Hepatitis C Virus-Like Particles and Viral Clearance in Acute and Chronic Hepatitis C. F Thomas S Wellnitz S Shigekiaono J Satio D Herion T Gerlach G Pape J Lau J Hoofnagle H Blum T Jake, Hepatology 2000 32 3 610 617 10.1053/jhep.2000.9876 10960457
5. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. AU Neumann NP Lam H Dahari, Science 1998 282 103 107 10.1126/science.282.5386.103 9756471
6. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. I Saito T Miyamura A Ohbayashi H Harada, Proc Natl Acad Sci USA 1990 87 6547 6549 10.1073/pnas.87.17.6547 2168552
7. Management of chronic hepatitis C. Postgrad. VL Re JR Kostman, Med J 2005 81 376 382
8. Global Epidemiology and Burden of Hepatitis C. WR Kim, Microbes Infect 2002 4 1219 1225 10.1016/S1286-4579(02)01649-0 12467763
9. Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. A Bari S Akhtar MH Rahbar, Trop Med Int Health 2001 6 732 738 10.1046/j.1365-3156.2001.00779.x 11555441
10. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. A Kabir SM Alavian H Keyvani, Comparative Hepatology 2006 5 4 10.1186/1476-5926-5-4 17014721
11. Epidemiology of hepatitis C virus (HCV) infection. T Syed MM Jamal, Int J Med Sci 2006 3 41 46 16614741
12. Molecular epidemiology of Hapatitis C Virus Genotypes in Khyber Pukhtoonkhaw of Pakistan. A Ali H Ahmad M Idrees, Virology J 2010 7 203 10.1186/1743-422X-7-203
13. General seroprevalence of hepatitis C and hepatitis B virus infections in population. N Khokhar ML Gill GJ Malik, J Coll Physicians Surg Pak 2004 149 534 536 (Pubitemid 39341726)
14. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. SP Luby K Qamruddin AA Shah, Epidemiol Infect 1997 119 349 356 10.1017/S0950268897007899 9440439
15. Hepatitis B and hepatitis C in Pakistan. AA Syed MJ Rafe H Qureshi SH Vermund, Int J Infect Dis 2009 13 9 19 10.1016/S1201-9712(09)60481-1 18835208
16. Factors influencing Hepatitis C virus sero-prevalence among blood donors in North West Pakistan. MN Khattak S Akhtar S Mahmud TM Roshan, J Public Health Policy 2008 29 207 225 10.1057/jphp.2008.7 18523475
17. Frequency of Hepatitis-C infection in Diabetic Patients. SS Ali IS Ali AM Amir Z Jadoon S Inayatullah, J Ayub Med Coll Abbottabad 2007 19 46 49 17867480
18. HCV detection in non-A, non-B patiens groups. ML Ribero F Tremolada S Chiaromonte, New challanges in blood banks screening and environment, Paris, October 1992, Interface Proceeding. Turnhout (Belgium), Polders I, Stuyck M, 1993 7 10
19. Worldwide variation in the relative importance of hepatitis B andhepatitis C viruses in hepatocellular carcinoma: a systematic review. SA Raza GM Clifford S Franceschi, Br J Cancer 2007 96 7 1127 1134 10.1038/sj.bjc. 6603649 17406349
20. Prevalence of HCV and HIV infections in 2005-Earthquak areas of Pakistan. S Khan MA Rai A Khan A Farooq SU Kazmi SH Ali, BMC Infect Dis 2008 8 147 10.1186/1471-2334-8-147 18954443
21. Global surveillance and control of hepatitis C. Anonymous, J Viral Hepat 1999 6 35 47 10.1046/j.1365-2893.1999.6120139.x 10847128
22. Management of chronic hepatitis C. RV Lo JR Kostman, Postgraduate Medical Journal 2005 81 376 382 10.1136/pgmj.2004.025403 15937203
23. Treatment of chronic hepatitis C in Europe. M Colombo MG Rumi ED Ninno, J Hepatobiliary Pancreat Surg 2003 10 168 1671 10.1007/s00534-002-0728-4 14505151
24. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. M Idrees S Riazuddin, BMC Infect Dis 2008 8 69 10.1186/1471-2334-8-69 18498666
25. Hepatitis C: the dermatologic profile. M Farhana I Hussain TS Haroon, J Pak Assoc Derm 2008 18 171 181
26. Seroprevalence of hepatitis B and C among the healthy blood donors at Fauji Foundation Hospital, Rawalpindi. IA Chaudhary U Samiullah SS Khan R Masood MA Sardar AA Mallhi, Pak J Med Sci 2007 23 64 67
27. Prevalence of hepatitis B, C and HIV in blood donors of South Punjab. W Jehangir F Ali U Shahnawaz T Iqbal HJ Qureshi, Esculapio 2006 2 6 7
28. Incidence of healthy voluntary blood donors at Faisalabad. ZY Hashmie AH Chaudhary M Ahmad M Ashraf, The Prof Med J 1999 6 551 555
29. Prevalence of HCV in blood donors. K Kazmi A Sadaruddin AS Dil SJ Zuberi, Pak J Med Res 1997 36 61 62
30. Seroprevalence and risk factors of Hepatitis C virus (HCV) in Mardan, N.W.F.P. MSA Khan M Khalid N Ayub M Javed, Rawal Med J 2004 29 57 60
31. Frequency of hepatitis C in Bunir, NWFP. N Muhammad A Jan, J Coll Physicians Surg Pak 2005 15 11 14 15670516
32. Demographic aspects of hepatitis C in Northern Pakistan. WU Tariq AB Hussain KA Karamat E Ghani T Hussain S Hussain, J Pak Med Assoc 1999 49 198 201 10641504
33. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. SA Ali M Rafe J Donahue H Qureshi SH Vermund, Int J Infect Dis 2009 13 9 19 10.1016/j.ijid.2008.06.019 18835208
34. Study of host and virus related factors associated with spontaneous hepatitis C clearance. L Arlic M Fort J Izopet JP Vinel C Bureau K Sandre JP Charlet M Beraud M Abbal M Duffaut, Tissue Antigens 2000 56 154 158 10.1034/j.1399-0039.2000.560207.x 11019916